Effects of Mineralocorticoid Receptor Antagonists on CV Outcomes in Patients With ESRD and HF
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Heart Failure
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The effects of mineralocorticoid receptor antagonists on cardiovascular outcomes in patients with end-stage renal disease and heart failure
Eur. J. Heart Fail 2022 Nov 20;[EPub Ahead of Print], DS Lin, FJ Lin, YS Lin, JK Lee, YH LinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.